Kristono Gisela A, Holley Ana S, Harding Scott A, Larsen Peter D
Department of Surgery and Anaesthesia, University of Otago Wellington.
Wellington Cardiovascular Research Group.
Coron Artery Dis. 2020 Aug;31(5):446-450. doi: 10.1097/MCA.0000000000000860.
White blood cell (WBC) subtypes have been associated with major adverse cardiovascular events (MACEs) in acute myocardial infarction (AMI). More recently, combining neutrophil and lymphocyte counts or lymphocyte and monocyte counts into a ratio has found to be promising for predicting MACE. This study aimed to confirm the association between MACE and the following WBC subtypes: neutrophils, lymphocytes, monocytes, neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR).
In a cohort of 860 AMI patients, we collected levels of WBC subtypes from the earliest blood tests recorded prior to angiography. Data on baseline demographics and one-year outcomes were also collected.
At one year, 130 patients (15.1%) developed MACE. NLR and LMR were significantly associated with MACE on univariate analysis (P = 0.006 and 0.005, respectively). However, when combined into a multivariate model with age, hypertension, prior myocardial infarction and Type 2 diabetes, neither NLR nor LMR had significant associations (odds ratio = 1.058 and 0.966, P = 0.069 and 0.612, respectively).
As NLR and LMR were correlated with MACE only on univariate analysis, we do not believe that they are predictive enough to be used alone in a clinical setting. Further studies are required to assess the prognostic ability of these ratios in combination with other inflammatory markers.
白细胞(WBC)亚型与急性心肌梗死(AMI)中的主要不良心血管事件(MACE)相关。最近,将中性粒细胞与淋巴细胞计数或淋巴细胞与单核细胞计数合并为一个比值已被发现对预测MACE很有前景。本研究旨在证实MACE与以下白细胞亚型之间的关联:中性粒细胞、淋巴细胞、单核细胞、中性粒细胞 - 淋巴细胞比值(NLR)和淋巴细胞 - 单核细胞比值(LMR)。
在一个由860例AMI患者组成的队列中,我们从血管造影术前记录的最早血液检测中收集白细胞亚型水平。还收集了基线人口统计学数据和一年期结局数据。
一年时,130例患者(15.1%)发生了MACE。在单因素分析中,NLR和LMR与MACE显著相关(P分别为0.006和0.005)。然而,当与年龄、高血压、既往心肌梗死和2型糖尿病合并纳入多变量模型时,NLR和LMR均无显著关联(比值比分别为1.058和0.966,P分别为0.069和0.612)。
由于NLR和LMR仅在单因素分析中与MACE相关,我们认为它们的预测性不足以在临床环境中单独使用。需要进一步研究来评估这些比值与其他炎症标志物联合使用时的预后能力。